Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001802768-25-000104

EVP & CFO acquired 3,696 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coyne Terrance P. EVP & CFO 2025-08-06 Grant or award +3,696 52,342 I
Derivatives
Coyne Terrance P. EVP & CFO 2025-08-08 Gift · LP interests in RPI US Partners 2019, LP −1,000 43,350 I
Loading xslF345X05/wk-form4_1754686694.xml…